TelomEye Pharmaceuticals provides treatments to prevent and improve age-related ophthalmologic disorders.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Nov 17, 2022 | Seed | $1M | 1 | Re-Pie Asset Management | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Re-Pie Asset Management | Yes | Seed |